|
REFERENCES
- Borras-Cuesta, F., Golvano,J., Garcı´a-Granero,M., Sarobe,P., Riezu-Boj,J.I., Huarte,E. and Lasarte,J. (2000) Specific and General HLA-DR Binding Motifs:
Comparison of Algorithms. Hum. Immunol,. 61, 266-278.
- Brusic,V., Rudy,G., Honeyman,G., Hammer, J. and Harrison, L. (1998b) Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics, 14(2), 121-30.
- Chicz,R.M., Urban,R.G., Gorga,J.C., Vignali,D.A., Lane,W.S. and Strominger,J.L. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med., 178(1), 27-47.
- Cochlovius,B., Stassar,M., Chriast,O., Raddrizzani,L., Hammer,J., Mytilineos,I. and Zoller,M. (2000) In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program. J. Immunol., 165, 4731-4741.
- Fridkis-Hareli,M., Rosloniec,E.F., Fugger,L. and Strominger,J.L. (2001) Synthetic Peptides that Inhibit Binding of the Collagen Type II 261-273 Epitope to Rheumatoid Arthritis-Associated HLA-DR1 and -DR4 Molecules and Collagen-Specific T-Cell Responses. Hum. Immunol., 61, 640-650 (2000).
- Hagman,M. (2000) Computer aided vaccine design. Science, 290, 80-82.
- Hammer,J., Bono,E., Gallazi,F., Belunis,C., Nagy,Z. and Singaglia,F. (1994) Precise prediction of major histocompatibility complex class II peptide interaction based on side chain scanning. J.Exp.Med., 180, 2353.
- Hammer,J., Valsasnini,P., Tolba,K., Bolin,D., Higelin,J., Takacs,B. and Sinigaglia,F. (1993) Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 74(1), 197-203.
- Harfouch-Hammoud,E., Walk,T., Otto,H., Jung,G., Bach,J.F., van Endert,P.M. and Caillat-Zucman,S. (1999) Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes. Diabetes., 48(10), 1937-47.
- Marshal,K.W., Wilson,K.J., Liang,J., Woods,A., Zaller,D. and Rothbard,J.B. (1995) Prediction of peptide affinity to HLA-DRB1*0401. J. Immunol., 154, 5927-5933.
- Max,H., Halder,T., Kalbus,M., Gnau,V., Jung,G. and Kalbacher,H. (1994) A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Hum Immunol., 41(1), 39-45.
- O'Sullivan,D., Sidney,J., Del Guercio,M.F., Colon,S.M. and Sette,A. (1991) Truncation analysis of several DR binding epitopes. J. Immunol., 146(4), 1240-6.
- Rammensee,H.G., Friede,T. and Stevanovic,S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
- Singh, H. and Raghava, G. P. S. (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics (In Press)
- Sette, A., Sidney, J., Oseroff, C., del Guercio, M.F., Southwood, S., Arrhenius, T., Powell, M.F., Colon, S.M., Gaeta, F.C. and Grey,H.M. (1993) HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol., 151(6), 3163-70.
- Southwood,S., Sidney,J., Kondo,A., del Guercio,M.F., Appella,E., Hoffman,S., Kubo,R.,T., Chesnut,R.W., Grey,H.M. and Sette,A. (1998) Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol, 160(7), 3363-73.
- Stassar,M.J., R addrizzani,L., Hammer,J. and Zoller,M. (2001) T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1. Immunobiology. 203(5), 743-55.
- Sturniolo,T., Bono,E., Ding,J., Raddrizzani,L., Tuercei,O., Sahin,U., Braxenthaler,M., Gallazzi,F., Protti,M.P., Sinigaglia,F. and Hammer,J. (1999) Generation of tissue-specific and promiscuous HLA ligand database using DNA microarrays and virtual HLA class II matrices. Nat. Biotech., 17, 555-561.
- Swets,J.A. (1988) Measuring the accuracy of diagnostic systems. Science.240(4857), 1285-93.
- Texier,C., Pouvelle,S., Busson,M., Herve,M., Charron,D., Menez,A. and Maillere,B. (2000) HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol., 164(6), 3177-84.
|
|